Alliar Annouces 2Q17 Results

Thursday, August 10, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

BELO HORIZONTE, Brazil, Aug. 9, 2017 /PRNewswire/ -- Centro de Imagem Diagnósticos S.A. ("Alliar" or "Company") (B3: AALR3),

announces today its results for the second quarter of 2017 (2Q17).

Highlights:

  • Net revenue1 growth of 20% YTD and 13% in Q2; same store sales of 13% e 11%;
  • Adjusted EBITDA of R$
    108.8 million
    YTD (+16%) and R$ 59.2 million in Q2 (+13%);
  • LTM EBITDA of R$ 218.8 million (R$ 227.5 million when annualizing acquisitions);
  • Net income growth of 224% YTD, reaching R$ 13.5 million and loss reversal in Q2, with a profit of R$ 4.7 million (+R$ 10.3 million vs 2Q16);
  • Net income after minority interests of R$ 9.7 million YTD and R$ 4.0 million in Q2 (vs. net loss of R$ 1.8 million and R$ 9.3 million in 2016);
  • Operating cash flow of R$ 72.6 million YTD (+2,105 bps) and 85% in Q2 (+3,057 bps);
  • Cash conversion of 67% YTD (+2,105 bps) and 85% in Q2 (+3,057 bps);
  • ROIC without goodwill of 15.8%;
  • Net promoter score (NPS) of 75.0%, 448 bps improvement vs. Q1;
  • Anticipation of the 2017/2018 organic expansion plan, with the opening of 2 new mega stores, totaling 4 openings in 2017.

(1) Excludes "construction revenue", accounting entry referring to the investment made at RBD (PPP Bahia).

For Further Information: ir.alliar.com   

CONTACT

INVESTOR RELATIONS TEAM Carlos Araujo | IRO Francisco de Paula | IR Manager Tel.: +5511 4369-1387 E-mail: [email protected]

View original content:http://www.prnewswire.com/news-releases/alliar-annouces-2q17-results-300502428.html

SOURCE Alliar



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Find a Doctor
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook